137 related articles for article (PubMed ID: 12171790)
1. Interleukin-1beta inhibits expression of p21(WAF1/CIP1) and p27(KIP1) and enhances proliferation in response to platelet-derived growth factor-BB in smooth muscle cells.
Nathe TJ; Deou J; Walsh B; Bourns B; Clowes AW; Daum G
Arterioscler Thromb Vasc Biol; 2002 Aug; 22(8):1293-8. PubMed ID: 12171790
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1).
Marra DE; Simoncini T; Liao JK
Circulation; 2000 Oct; 102(17):2124-30. PubMed ID: 11044431
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms.
Servant MJ; Coulombe P; Turgeon B; Meloche S
J Cell Biol; 2000 Feb; 148(3):543-56. PubMed ID: 10662779
[TBL] [Abstract][Full Text] [Related]
4. TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27.
Hupfeld CJ; Weiss RH
Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E207-16. PubMed ID: 11440895
[TBL] [Abstract][Full Text] [Related]
5. Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53.
Takahashi A; Taniguchi T; Ishikawa Y; Yokoyama M
Circ Res; 1999 Mar; 84(5):543-50. PubMed ID: 10082476
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade.
Yang Z; Krasnici N; Lüscher TF
Circulation; 1999 Jul; 100(1):5-8. PubMed ID: 10393673
[TBL] [Abstract][Full Text] [Related]
8. Convergence of physical and chemical signaling in the modulation of vascular smooth muscle cell cycle and proliferation by fibrillar collagen-regulated P66Shc.
Yeh YT; Lee CI; Lim SH; Chen LJ; Wang WL; Chuang YJ; Chiu JJ
Biomaterials; 2012 Oct; 33(28):6728-38. PubMed ID: 22770800
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of p27kip1 levels and CDK activities by hypertrophic and hyperplastic agents in vascular smooth muscle cells.
Rao GN
Biochim Biophys Acta; 1999 Jan; 1448(3):525-32. PubMed ID: 9990305
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1beta inhibits PDGF-BB-induced migration by cooperating with PDGF-BB to induce cyclooxygenase-2 expression in baboon aortic smooth muscle cells.
Englesbe MJ; Deou J; Bourns BD; Clowes AW; Daum G
J Vasc Surg; 2004 May; 39(5):1091-6. PubMed ID: 15111866
[TBL] [Abstract][Full Text] [Related]
11. p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation.
Weiss RH; Joo A; Randour C
J Biol Chem; 2000 Apr; 275(14):10285-90. PubMed ID: 10744715
[TBL] [Abstract][Full Text] [Related]
12. Laminar shear stress inhibits vascular endothelial cell proliferation by inducing cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1).
Akimoto S; Mitsumata M; Sasaguri T; Yoshida Y
Circ Res; 2000 Feb; 86(2):185-90. PubMed ID: 10666414
[TBL] [Abstract][Full Text] [Related]
13. Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation.
Fukumoto S; Koyama H; Hosoi M; Yamakawa K; Tanaka S; Morii H; Nishizawa Y
Circ Res; 1999 Nov; 85(11):985-91. PubMed ID: 10571528
[TBL] [Abstract][Full Text] [Related]
14. Synergistic roles of platelet-derived growth factor-BB and interleukin-1beta in phenotypic modulation of human aortic smooth muscle cells.
Chen CN; Li YS; Yeh YT; Lee PL; Usami S; Chien S; Chiu JJ
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2665-70. PubMed ID: 16477012
[TBL] [Abstract][Full Text] [Related]
15. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
[TBL] [Abstract][Full Text] [Related]
16. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.
Coats S; Whyte P; Fero ML; Lacy S; Chung G; Randel E; Firpo E; Roberts JM
Curr Biol; 1999 Feb; 9(4):163-73. PubMed ID: 10074425
[TBL] [Abstract][Full Text] [Related]
17. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
18. The permissive effect of p21(Waf1/Cip1) on DNA synthesis is dependent on cell type: effect is absent in p53-inactive cells.
Weiss RH; Randour CJ
Cell Signal; 2000 Jun; 12(6):413-8. PubMed ID: 10889470
[TBL] [Abstract][Full Text] [Related]
19. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors.
Koyama H; Raines EW; Bornfeldt KE; Roberts JM; Ross R
Cell; 1996 Dec; 87(6):1069-78. PubMed ID: 8978611
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
